An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Express Worries
However, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, legal action or prison.
Service Response and Material Elimination
According to the social media company, the service has taken down problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also discovered communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
Within moments of joining one community, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or past usage.
Item Details and Pricing
Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A representative for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to potentially significant medical dangers”.
